<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03073980</url>
  </required_header>
  <id_info>
    <org_study_id>2016P002465</org_study_id>
    <nct_id>NCT03073980</nct_id>
  </id_info>
  <brief_title>Assessing Efficacy of IV Acetaminophen for Perioperative Pain Control for Oocyte Retrieval</brief_title>
  <official_title>Assessing Efficacy of IV Acetaminophen for Perioperative Pain Control for Oocyte Retrieval: a Randomized, Double Blind, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this research study we want to learn more about how effective certain medications are at&#xD;
      reducing pain after oocyte (egg) retrieval surgery and how effective they are at reducing the&#xD;
      time between the retrieval and discharge from the hospital. We will compare three types of&#xD;
      pre-operative medications: intravenous (IV) acetaminophen, oral (PO) acetaminophen, and&#xD;
      placebo (no medication), which is the current typical care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVE: To compare the efficacy of pre-operative IV acetaminophen, PO acetaminophen,&#xD;
      versus placebo for adjunctive pain control in the setting of oocyte retrieval in an in vitro&#xD;
      fertilization clinic setting.&#xD;
&#xD;
      HYPOTHESIS: Our hypothesis is that patients receiving IV acetaminophen pre-operatively will&#xD;
      have improved postoperative pain scores, lower overall opiate consumption, and shortened time&#xD;
      to discharge from PACU than those receiving PO acetaminophen or placebo.&#xD;
&#xD;
      Participants will be consented and enrolled in the study prior to their oocyte retrieval. The&#xD;
      patient will then be randomized to one of three treatments:&#xD;
&#xD;
      Group 1: In the pre-op suite, these patients will receive 1000mg IV acetaminophen and PO&#xD;
      placebo, followed by standard protocol anesthesia and pain control as needed.&#xD;
&#xD;
      Group 2: In the pre-op suite, these patients will receive 1000mg PO acetaminophen and IV&#xD;
      placebo, followed by standard protocol anesthesia and pain control as needed.&#xD;
&#xD;
      Group 3:&#xD;
&#xD;
      In the pre-op suite, these patients will receive PO and IV placebo, followed by standard&#xD;
      protocol anesthesia and pain control as needed.&#xD;
&#xD;
      The patient and care team will be blinded to the treatment group.&#xD;
&#xD;
      A member of the study staff will review participants' medical record to collect data&#xD;
      regarding demographics, clinical history, cycle and pregnancy outcomes, up to 12 months&#xD;
      following study completion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain control and opiate requirements</measure>
    <time_frame>In PACU and through post-operative day 2</time_frame>
    <description>Visual pain score, rescue pain medication use</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to discharge from PACU</measure>
    <time_frame>0-6 hours post-procedure</time_frame>
    <description>Visual pain score, recovery assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure length</measure>
    <time_frame>0-2 hours</time_frame>
    <description>Duration of egg retrieval</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>0-2 days</time_frame>
    <description>Postoperative nausea and vomiting in PACU and through POD2 (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryology outcomes</measure>
    <time_frame>0-7 days</time_frame>
    <description>Oocyte yield, fertilization rate, blastocyst rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy outcomes</measure>
    <time_frame>Up to one year</time_frame>
    <description>Implantation rate, miscarriage rate, pregnancy rate, live birth (&gt;24 weeks gestation) rate</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">174</enrollment>
  <condition>Infertility, Female</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Group 1: IV acetaminophen/PO placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the pre-op suite, these patients will receive 1000mg IV acetaminophen and PO placebo, followed by standard protocol anesthesia and pain control as needed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: IV placebo/PO acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the pre-op suite, these patients will receive 1000mg PO acetaminophen and IV placebo, followed by standard protocol anesthesia and pain control as needed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3: Placebo / Standard of care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In the pre-op suite, these patients will receive PO and IV placebo, followed by standard protocol anesthesia and pain control as needed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Acetaminophen</intervention_name>
    <description>IV Acetaminophen for pain control during procedure</description>
    <arm_group_label>Group 1: IV acetaminophen/PO placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PO Acetaminophen</intervention_name>
    <description>PO Acetaminophen for pain control during procedure</description>
    <arm_group_label>Group 2: IV placebo/PO acetaminophen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo IV Acetaminophen</intervention_name>
    <description>Placebo IV Acetaminophen</description>
    <arm_group_label>Group 2: IV placebo/PO acetaminophen</arm_group_label>
    <arm_group_label>Group 3: Placebo / Standard of care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo PO Acetaminophen</intervention_name>
    <description>Placebo PO Acetaminophen</description>
    <arm_group_label>Group 1: IV acetaminophen/PO placebo</arm_group_label>
    <arm_group_label>Group 3: Placebo / Standard of care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        [ ] Patient is 18 years or over, undergoing oocyte retrieval. [ ] Patient is&#xD;
        English-speaking.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        [ ] Allergy/hypersensitivity to acetaminophen or opiates. [ ] Any history of liver disease,&#xD;
        history of alcohol depending, or renal impairment as reported in the electronic health&#xD;
        record.&#xD;
&#xD;
        [ ] Any history chronic opiate use or chronic pain disorder reported in the electronic&#xD;
        health record.&#xD;
&#xD;
        [ ] Weight less than 50kg as reported in the medical record.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John C Petrozza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabel Chico Calero, PhD</last_name>
    <phone>617-278-1134</phone>
    <email>ichicocalero@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caitlin Sacha, MD</last_name>
      <phone>617-726-8868</phone>
      <email>csacha@partners.org</email>
    </contact>
    <contact_backup>
      <last_name>John C Petrozza, MD</last_name>
      <phone>617-726-8868</phone>
    </contact_backup>
    <investigator>
      <last_name>John Petrozza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caitlin Sacha, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Hsu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 22, 2017</study_first_submitted>
  <study_first_submitted_qc>March 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>John C Petrozza</investigator_full_name>
    <investigator_title>Chief, Division of Reproductive Medicine and IVF, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>in vitro fertilization</keyword>
  <keyword>oocyte retrieval</keyword>
  <keyword>acetaminophen</keyword>
  <keyword>postoperative pain control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

